生物标志物 生物标志物
Salah Aziz1, Romeo Penheiro2, Cassandra Morrison1
1Carleton University, Ottawa, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
海马体积减少是阿尔茨海默病 (AD) 的关键指标. 基于表面的形态特征,如曲率和厚度,为阿尔茨海默病的进展和认知衰退提供了更深入的见解,补充了传统的体积测量.
科学领域:
- 神经成像是一种神经成像.
- 阿尔茨海默氏症疾病研究研究
- 大脑形态学 大脑形态学
背景情况:
- 海马在阿尔茨海默病 (AD) 中至关重要,病理表现为大脑缩和认知衰退.
- 虽然海马体积损失是已知的AD标志物,但基于表面的形态学 (SBM) 特性,如曲率,旋转和厚度等,理解较少.
- 阿尔茨海默病的进展包括从健康的衰老过渡到轻度认知障碍 (MCI) 和阿尔茨海默病,其特点是记忆障碍.
研究的目的:
- 研究海马表面基形态特征 (SBM) 在阿尔茨海默病 (AD) 进展中的作用.
- 为了比较不同认知轨迹的海马体积和SBM指标的变化.
- 确定特定的SBM特征与AD影响的认知领域之间的关系.
主要方法:
- 使用HippUnfold工具分析来自阿尔茨海默病神经成像计划 (ADNI) 的T1加权MRI数据.
- 基于最终诊断和认知轨迹 (稳定与进展者) 的参与者的分类 (CN,MCI,AD).
- 应用线性混合效应模型来评估海马体积和SBM指标 (曲率,旋转,厚度) 随着时间的推移,调整共变量.
主要成果:
- 与对照组相比,在稳定的AD组中观察到显著的海马体积减少.
- 所有SBM指标 (曲率,旋转,厚度) 在疾病阶段和随着时间的推移都显示出显著的变化.
- 体积变化主要与记忆和执行功能缺陷相关,而SBM指标影响了语言和视觉空间能力.
结论:
- 基于表面的形态特征为AD病理学提供了宝贵的见解,超出了海马体积减少.
- 将SBM指标与体积分析集成,可以提高对AD机制的理解.
- 这些发现强调了SBM特征在改善AD诊断和治疗策略方面的潜力.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516